A detailed history of Nbc Securities, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 500 shares of REGN stock, worth $346,750. This represents 0.02% of its overall portfolio holdings.

Number of Shares
500
Previous 91 449.45%
Holding current value
$346,750
Previous $47,000 497.87%
% of portfolio
0.02%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$534.91 - $598.71 $218,778 - $244,872
409 Added 449.45%
500 $281,000
Q2 2025

Jul 08, 2025

SELL
$483.07 - $625.6 $15,458 - $20,019
-32 Reduced 26.02%
91 $47,000
Q1 2025

Apr 09, 2025

BUY
$634.14 - $744.83 $77,999 - $91,614
123 New
123 $78,000
Q3 2024

Oct 15, 2024

SELL
$1024.09 - $1201.76 $43,011 - $50,473
-42 Reduced 20.79%
160 $168,000
Q1 2024

Apr 05, 2024

BUY
$902.69 - $993.35 $902 - $993
1 Added 0.5%
202 $194,000
Q3 2023

Nov 03, 2023

BUY
$692.45 - $844.37 $139,182 - $169,718
201 New
201 $165,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.